G KEARNS
Role not yet determined Is this you? Add your title
Also affiliated: Arkansas Children's Hospital (1990–2015); Nationwide Children's Hospital (2001); Children's Mercy Hospital (1999–2012); University of North Carolina Health Care (1999); Baylor College of Medicine (1999); University of Washington (1999); Purdue University West Lafayette (2001); American Pharmacists Association (1999); Erasmus MC (2001); Endocrinology Research Center (1999); Mercy Hospital (1999); Bassett Healthcare Network (1999); Purdue University Institute for Cancer Research (2001); Indiana University – Purdue University Indianapolis (2005); University of Missouri–Kansas City (1999–2012)
Formerly Arkansas Affiliated with UAMS through 2015.
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
G Kearns' research focuses on human pharmacokinetics, particularly in pediatric populations. Their work has investigated drug metabolism and variability in drug response, examining factors such as sex and individual susceptibility. Recent publications include studies on glucuronidation in humans, the role of hepatic metabolism in serum sickness-like reactions to cefaclor, and the activity of specific enzymes like CYP1A2 and N-acetyltransferase-2. Kearns has also explored the impact of developmental pharmacology on pediatric study design and investigated terbinafine as a CYP2D6 inhibitor. Further research has involved single-dose pharmacokinetics of linezolid in infants and children and explored new perspectives on histamine as a mediator. Kearns has a h-index of 12, with 37 publications and 617 citations.
Metrics
- h-index: 12
- Publications: 37
- Citations: 617
Selected Publications
-
Selecting the proper pediatric dose: It is more than size that matters (2015)
-
Hepatic drug clearance in patients with mild cystic fibrosis* (1996)
-
Protracted Methemoglobinemia after Phenazopyridine Overdose in an Infant (1996)
-
Serum sickness–like reactions to cefaclor: Role of hepatic metabolism and individual susceptibility (1994)
Collaboration Network
Top Collaborators
- Use of continuous infusion of pralidoxime for treatment of organophosphate poisoning in children
- Protracted Methemoglobinemia after Phenazopyridine Overdose in an Infant
- Protracted Methemoglobinemia after Phenazopyridine Overdose in an Infant
- Use of continuous infusion of pralidoxime for treatment of organophosphate poisoning in children
- Paediatric Labelling Requirements
- Paediatric Labelling Requirements
- Paediatric Labelling Requirements
- Hepatic drug clearance in patients with mild cystic fibrosis*
- Hepatic drug clearance in patients with mild cystic fibrosis*
- Hepatic drug clearance in patients with mild cystic fibrosis*
- Hepatic drug clearance in patients with mild cystic fibrosis*
- Ceftibuten Pharmacokinetics and Pharmacodynamics
- Pharmacokinetic Studies in Paediatric Patients
- Serum sickness–like reactions to cefaclor: Role of hepatic metabolism and individual susceptibility
- Serum sickness–like reactions to cefaclor: Role of hepatic metabolism and individual susceptibility
- Serum sickness–like reactions to cefaclor: Role of hepatic metabolism and individual susceptibility
Similar Researchers
Based on overlapping research topics